Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| mast cell | 11 studies | 25% ± 10% | |
| epithelial cell | 5 studies | 36% ± 14% | |
| endothelial cell | 4 studies | 22% ± 3% | |
| enterocyte | 4 studies | 25% ± 6% | |
| ciliated cell | 4 studies | 28% ± 7% | |
| astrocyte | 4 studies | 23% ± 7% | |
| oligodendrocyte | 4 studies | 21% ± 3% | |
| CD4-positive, alpha-beta T cell | 3 studies | 21% ± 4% | |
| conventional dendritic cell | 3 studies | 25% ± 9% | |
| hematopoietic precursor cell | 3 studies | 20% ± 2% | |
| kidney loop of Henle epithelial cell | 3 studies | 16% ± 1% | |
| macrophage | 3 studies | 26% ± 4% | |
| GABAergic neuron | 3 studies | 34% ± 2% | |
| glutamatergic neuron | 3 studies | 34% ± 5% | |
| dendritic cell | 3 studies | 30% ± 3% | |
| natural killer cell | 3 studies | 18% ± 3% | |
| goblet cell | 3 studies | 25% ± 3% | |
| basal cell | 3 studies | 28% ± 7% | |
| plasmacytoid dendritic cell | 3 studies | 21% ± 3% | |
| luminal hormone-sensing cell of mammary gland | 3 studies | 22% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 699.18 | 653 / 653 | 100% | 58.90 | 604 / 605 |
| breast | 100% | 760.52 | 459 / 459 | 100% | 74.66 | 1115 / 1118 |
| uterus | 100% | 471.76 | 170 / 170 | 100% | 50.79 | 457 / 459 |
| esophagus | 100% | 590.61 | 1445 / 1445 | 99% | 26.08 | 182 / 183 |
| intestine | 100% | 941.92 | 966 / 966 | 99% | 52.36 | 524 / 527 |
| prostate | 100% | 560.98 | 245 / 245 | 99% | 45.87 | 499 / 502 |
| lung | 100% | 591.82 | 577 / 578 | 100% | 40.98 | 1150 / 1155 |
| stomach | 100% | 490.39 | 359 / 359 | 99% | 42.37 | 284 / 286 |
| ovary | 99% | 400.83 | 179 / 180 | 100% | 38.22 | 429 / 430 |
| kidney | 100% | 961.01 | 89 / 89 | 99% | 32.22 | 892 / 901 |
| liver | 100% | 379.73 | 226 / 226 | 98% | 25.12 | 399 / 406 |
| brain | 99% | 334.47 | 2603 / 2642 | 100% | 36.89 | 703 / 705 |
| bladder | 100% | 522.62 | 21 / 21 | 98% | 41.30 | 493 / 504 |
| pancreas | 99% | 281.39 | 324 / 328 | 98% | 29.55 | 175 / 178 |
| skin | 100% | 705.07 | 1808 / 1809 | 97% | 33.96 | 456 / 472 |
| adrenal gland | 100% | 702.16 | 258 / 258 | 87% | 15.21 | 199 / 230 |
| adipose | 100% | 597.71 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 67.84 | 29 / 29 |
| muscle | 100% | 874.46 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 588.88 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 64.08 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 13.31 | 1 / 1 |
| blood vessel | 99% | 439.80 | 1328 / 1335 | 0% | 0 | 0 / 0 |
| heart | 98% | 818.63 | 843 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 95% | 24.86 | 76 / 80 |
| peripheral blood | 94% | 652.57 | 871 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006935 | Biological process | chemotaxis |
| GO_0006954 | Biological process | inflammatory response |
| GO_0010756 | Biological process | positive regulation of plasminogen activation |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PLGRKT |
| Protein name | Plasminogen receptor (KT) (Plg-R(KT)) |
| Synonyms | C9orf46 MDS030 AD025 |
| Description | FUNCTION: Receptor for plasminogen. Regulates urokinase plasminogen activator-dependent and stimulates tissue-type plasminogen activator-dependent cell surface plasminogen activation. Proposed to be part of a local catecholaminergic cell plasminogen activation system that regulates neuroendocrine prohormone processing. Involved in regulation of inflammatory response; regulates monocyte chemotactic migration and matrix metalloproteinase activation, such as of MMP2 and MMP9. . |
| Accessions | Q9HBL7 ENST00000223864.7 |